CD274 and glioblastoma: To demonstrate the activation of the PD-1/PD-L1 system in glioblastoma, IHC staining of tumor tissues from patients of the clinical trial CAR2BRAIN was performed, where robust PD-L1 upregulation was found already prior to study treatment [Fig. 1c].